Frazier Life Sciences Management, L.P. Immunocore Holdings PLC Transaction History
Frazier Life Sciences Management, L.P.
- $2.36 Billion
- Q3 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 384,782 shares of IMCR stock, worth $13.8 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
384,782
Previous 384,782
-0.0%
Holding current value
$13.8 Million
Previous $12.1 Million
15.78%
% of portfolio
0.59%
Previous 0.64%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
146Shares Held
46.9MCall Options Held
325KPut Options Held
1.74M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.06MShares$254 Million0.16% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$175 Million2.36% of portfolio
-
Wellington Management Group LLP Boston, MA4.78MShares$172 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.75MShares$135 Million0.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.8MShares$101 Million2.17% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.58B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...